NCT02754037Active, not recruiting
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The goal of this study is to evaluate non-invasive imaging techniques for determining liver steatosis (fat), inflammation (abnormal tissue swelling), and fibrosis (abnormal tissue scarring).In addition, the study group will be using other test measures including personal demographics, laboratory blood test results, and imaging measurements to determine the severity of NAFLD (non-alcoholic fatty liver disease), NASH (non-alcoholic steatohepatitis), inflammation, and fibrosis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 26 Apr 2016
- Start date
- 30 Apr 2016
- Primary completion date
- 14 Jul 2027
- Lead sponsor
- University of California, Davis
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT02754037
What you commit to
- Study type: Observational
- Planned participants: 120
- From 30 Apr 2016 to the primary completion date, 14 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of alcohol abuse, chronic hepatitis B or C, or other chronic liver disease other than non-alcoholic fatty liver disease.
- Allergic to FDG dye
Other
- Pregnant women
- Prisoners
- Claustrophobic to MRI
- Patients who are unable to lie in the scanner for one hour
Who the study is looking for
- Patients \>18 years age
- Patients who had or will have a liver biopsy as standard of care for fatty liver disease and have risk factors for NASH. Liver biopsy needs to be within 6 months of planned imaging.
- Patients undergoing bariatric surgery and will have a liver biopsy as standard of care.
- Ability to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California, Davis Medical Center Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.